Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

OBJECTIVE: To compare the incidence of cardiovascular events and mortality in patients with type 2 diabetes mellitus treated with sitagliptin or non-sitagliptin comparators. METHODS: A post hoc assessment of cardiovascular safety in 14,611 patients was performed by pooling data from 25 double-blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Samuel S, Golm, Gregory T, Shapiro, Deborah, Davies, Michael J, Kaufman, Keith D, Goldstein, Barry J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585887/
https://www.ncbi.nlm.nih.gov/pubmed/23286208
http://dx.doi.org/10.1186/1475-2840-12-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585887/
https://www.ncbi.nlm.nih.gov/pubmed/23286208
http://dx.doi.org/10.1186/1475-2840-12-3

Ejemplares similares